
ST AIA-PACK cTnI 3rd-Gen is designed for in-vitro
Part #: 0025215
Manufacturers:
Troponin I (TnI) has three isoforms: cardiac, fast skeletal and slow skeletal and out of them cardiac troponin I (cTnI) is highly specific to the myocardium. When the myocardium is damaged, cTnI is released into the blood. The level of cTnI becomes abnormally high 3-4 hours after the onset of acute myocardial infarction and reaches the peak 10-16 hours after the onset. The level of cTnI remains abnormally high for 5-8 days after the onset. When compared to Myoglobin or CK-MB, the degree of its change in relation to the cut-off value is much greater for cTnI (undetectable in healthy individuals) and as a result, it is possible to detect minute myocardial lesions. In addition, increased cTnI levels in heart failure patients indicates latent cardiomyopathy.
Technical specifications
| Kit name | ST AIA-PACK cTnI 3rd-Gen |
| Method | Enzyme Immunoassay (EIA) |
| Assay principle | Two-site immunoenzymometric assay |
| Assay sample | Serum, heparinized plasma or EDTA plasma |
| Calibrators | 0, 0.2, 1.0, 5.0, 20, 60 ng/mL |
| Standardization | Internal |
| Calibration stability | 90 days |
| Assay range | 0.02 - 50 ng/mL |
| Reaction time | 10 minutes |
| Hook effect | >20,000 ng/mL |
| Storage | 2 - 8oC |
Refer to the product Instruction-For-Use (IFU) for complete details.